DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells

BACKGROUND: Renal cell carcinoma (RCC) is a complex with diverse biological characteristics and distinct molecular signature. New target therapies to molecules that drive RCC initiation and progression have achieved promising responses in some patients, but the total effective rate is still far from...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Qian, Han, Na, Yuan, Xun, Nie, Xin, Wu, Hua, Chen, Yu, Guo, Mingzhou, Yu, Shiying, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203876/
https://www.ncbi.nlm.nih.gov/pubmed/25322986
http://dx.doi.org/10.1186/s13045-014-0073-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203876/
https://www.ncbi.nlm.nih.gov/pubmed/25322986
http://dx.doi.org/10.1186/s13045-014-0073-5

Ejemplares similares